RetinalGenix Technologies annual operating expenses
2020
2021
2022
2023
2024
2025
RetinalGenix Technologies Operating Expenses Growth & History (RTGN)
RetinalGenix Technologies's operating expenses was $2.4M for fiscal 2025.
View full RetinalGenix Technologies company overviewRetinalGenix Technologies annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $2.4M | −$1.9M | −43.84% |
| 2024 | 2024-12-31 | $4.3M | $2.2M | +106.85% |
| 2023 | 2023-12-31 | $2.1M | −$1.8M | −46.61% |
| 2022 | 2022-12-31 | $3.9M | $1.7M | +79.58% |
| 2021 | 2021-12-31 | $2.2M | $98,682 | +4.75% |
| 2020 | 2020-12-31 | $2.1M | — | — |
RetinalGenix Technologies quarterly operating expenses
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $303,442 | −$344,906 | −53.20% |
| Q1 2026 | 2026-03-31 | $589,229 | $2,879 | +0.49% |
| Q4 2025 | 2025-12-31 | $622,059 | −$244,008 | −28.17% |
| Q3 2025 | 2025-09-30 | $567,833 | −$75,498 | −11.74% |
| Q2 2025 | 2025-06-30 | $648,348 | −$14,325 | −2.16% |
| Q1 2025 | 2025-03-31 | $586,350 | −$1.6M | −72.66% |
| Q4 2024 | 2024-12-31 | $866,067 | $325,391 | +60.18% |
| Q3 2024 | 2024-09-30 | $643,331 | −$42,176 | −6.15% |
| Q2 2024 | 2024-06-30 | $662,673 | $311,490 | +88.70% |
| Q1 2024 | 2024-03-31 | $2.1M | $1.6M | +320.83% |
| Q4 2023 | 2023-12-31 | $540,676 | −$133,330 | −19.78% |
| Q3 2023 | 2023-09-30 | $685,507 | −$1.8M | −72.62% |
| Q2 2023 | 2023-06-30 | $351,183 | −$6,692 | −1.87% |
| Q1 2023 | 2023-03-31 | $509,683 | $135,944 | +36.37% |
| Q4 2022 | 2022-12-31 | $674,006 | $265,707 | +65.08% |
| Q3 2022 | 2022-09-30 | $2.5M | $2.0M | +355.26% |
| Q2 2022 | 2022-06-30 | $357,875 | −$176,977 | −33.09% |
| Q1 2022 | 2022-03-31 | $373,739 | −$309,942 | −45.33% |
| Q4 2021 | 2021-12-31 | $408,299 | — | — |
| Q3 2021 | 2021-09-30 | $549,843 | −$17,255 | −3.04% |
| Q2 2021 | 2021-06-30 | $534,852 | — | — |
| Q1 2021 | 2021-03-31 | $683,681 | — | — |
| Q3 2020 | 2020-09-30 | $567,098 | — | — |
RetinalGenix Technologies operating expenses trends
Over the last five fiscal years, RetinalGenix Technologies's operating expenses increased from $2.1M to $2.4M, a change of $346,597. The latest reported quarter, Q2 2026, shows $303,442.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review RetinalGenix Technologies source filings ↗